Meanwhile, the FDA delays Glaxo cervical cancer vaccine ruling: <a href="http://www.msnbc.msn.com/id/33073409/ns/health-cancer/" rel="nofollow" target="_blank">http://www.msnbc.msn.com/id/33073409/ns/health-cancer/</a> Glaxo spokeswoman Sarah Alspach said the death did not influence the FDA's decision to extend its review.